Late effects – the new focus of follow-up

Christoffer Johansena Department of Oncology, Cancer late effect research unit CASTLE, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkCorrespondence[email protected]

Annika von Heymanna Department of Oncology, Cancer late effect research unit CASTLE, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

https://orcid.org/0000-0002-0900-5575

Bolette S. Rafna Department of Oncology, Cancer late effect research unit CASTLE, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Signe Borgquistb Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

https://orcid.org/0000-0001-7938-8893

Peer Christiansenc Department of Plastic and Breast Surgery, Aarhus University Hospital, Aarhus, Denmark

Peter Christensend Department of Surgery P, Aarhus University Hospital, Aarhus, Denmark

Robert Zachariaeb Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

Helle Pappote Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Ulrik Lassene Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

show all

References

Høeg BL, Bidstrup PE, Karlsen RV, et al. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev. 2019;(11):1–173.
Web of Science ®Google Scholar
Di Maio M, Basch E, Denis F, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO clinical practice guideline. Ann Oncol. 2022;33(9):878–892.
PubMed Web of Science ®Google Scholar
Emery J, Butow P, Lai-Kwon J, et al. Management of common clinical problems experienced by survivors of cancer. Lancet. 2022;399(10334):1537–1550.
PubMed Web of Science ®Google Scholar
Dalton SO, Olsen MH, Johansen C, et al. Socioeconomic inequality in cancer survival - changes over time. A population-based study, Denmark, 1987-2013. Acta Oncol. 2019;58(5):737–744.
PubMed Web of Science ®Google Scholar
Saltbaek L, Karlsen RV, Bidstrup PE, et al. MyHealth: specialist nurse-led follow-up in breast cancer. A randomized controlled trial - development and feasibility. Acta Oncol. 2019;58(5):619–626.
PubMed Web of Science ®Google Scholar
Absolom K, Warrington L, Hudson E, et al. Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy. J Clin Oncol. 2021;39(7):734–747.
PubMed Web of Science ®Google Scholar
Pappot H, Baeksted CW, Nissen A, et al. Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study. Breast Cancer. 2021;28(5):1096–1099.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Late effects – the new focus of follow-up

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Late effects – the new focus of follow-up

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date